This document provides information about various components of a complete blood count (CBC) test, including white blood cell (WBC), red blood cell (RBC), and platelet counts. It describes what each test measures, its normal reference ranges, potential abnormal findings and their implications. Nursing considerations are outlined for preparing patients for CBC testing and interpreting results. The document also discusses the blood urea nitrogen (BUN) test and how it is used to evaluate kidney function. In summary, it reviews several common blood tests, what they indicate about a patient's health, and nursing responsibilities related to ordering and following up on the tests.
The document discusses renal circulation, regulation of renal blood flow, nephron anatomy and physiology, and effects of various drugs on renal function. The key points are:
1) The kidneys receive 20-25% of cardiac output despite only weighing 0.4% of body weight. Renal blood flow is regulated by neural, hormonal and local factors to maintain glomerular filtration.
2) Nephrons contain a loop of Henle that acts as a countercurrent multiplier to concentrate urine by establishing an osmotic gradient in the renal medulla, aided by countercurrent exchange in vasa recta capillaries.
3) Drugs like NSAIDs, ACE inhibitors, intravenous agents
This document discusses various types of endoscopy procedures. It describes cholangioscopy, which is used to treat bile duct stones and evaluate biliary strictures. Endoscopic fistula closure is discussed as a way to close gastrointestinal perforations. Endoscopic mucosal resection and endoscopic submucosal dissection are described as minimally invasive techniques to remove benign and early malignant lesions. Upper endoscopy and colonoscopy are summarized as procedures to examine the upper and lower gastrointestinal tract respectively. Potential risks associated with these endoscopic procedures include sedation side effects, bleeding, perforation, and infection.
This document discusses renal function tests and their use in evaluating kidney function. It describes the key functions of the kidney including fluid balance, waste excretion, blood pressure regulation, vitamin D and erythropoietin production. Tests are classified as evaluating glomerular function like glomerular filtration rate (GFR) tests or tubular function. GFR is best measured by creatinine clearance or equations using creatinine, age, and other factors. Urine and blood tests can indicate glomerular or tubular dysfunction. Clearance tests measure the removal of substances from blood by the kidneys. Renal biopsy may be used to diagnose kidney disease when function tests are unclear.
Renal biopsy is a procedure to obtain small pieces of kidney tissue for examination under a microscope. It provides valuable information about kidney disease by determining the cause, severity, and best treatment. Indications for renal biopsy include nephrotic syndrome, kidney disease with a systemic condition, acute kidney failure, and in renal transplants. Complications can include bleeding, pain, and fistula formation, but are generally rare. The biopsy results help establish a diagnosis and guide management of kidney disorders.
The document discusses various diagnostic tests involving visualization of body structures and functions. It describes procedures like endoscopy, colonoscopy and sigmoidoscopy which allow direct visualization of the gastrointestinal tract. Indirect visualization is achieved through radiographic imaging using barium and fluoroscopy. Procedures for visualizing the urinary system like IV pyelogram, cystoscopy and renal ultrasonography are also outlined. The document also discusses various cardiac diagnostic tests including electrocardiography, echocardiogram, stress testing and angiography. Visualization of the lungs can be achieved through procedures like bronchoscopy.
A kidney transplant involves surgically removing a healthy kidney from a living or deceased donor and implanting it into a recipient with kidney failure. The recipient must take lifelong immunosuppressive drugs to prevent rejection of the new organ. Complications can include infection, cardiovascular issues, and cancer due to immunosuppression. Care after transplant focuses on monitoring for signs of rejection like changes in urine output or kidney function tests and treating rejection promptly if it occurs. Long term management also involves managing side effects of immunosuppressants and screening for related health issues.
Coronary angiography is an x-ray examination of the heart's blood vessels. A small tube called a catheter is inserted into a blood vessel in the groin or arm and guided to the heart. A contrast dye is injected through the catheter to make the blood vessels visible on x-rays called angiograms. Preparation for coronary angiography involves explaining the procedure to the patient, obtaining consent, checking blood work and vital signs, preparing the insertion site, and providing psychological support and pre-medication. During the procedure, the patient's position and hemodynamics are monitored and contrast is injected to visualize the coronary arteries. Afterward, the sheath is removed, the site is dressed, and the patient is monitored
The document discusses renal circulation, regulation of renal blood flow, nephron anatomy and physiology, and effects of various drugs on renal function. The key points are:
1) The kidneys receive 20-25% of cardiac output despite only weighing 0.4% of body weight. Renal blood flow is regulated by neural, hormonal and local factors to maintain glomerular filtration.
2) Nephrons contain a loop of Henle that acts as a countercurrent multiplier to concentrate urine by establishing an osmotic gradient in the renal medulla, aided by countercurrent exchange in vasa recta capillaries.
3) Drugs like NSAIDs, ACE inhibitors, intravenous agents
This document discusses various types of endoscopy procedures. It describes cholangioscopy, which is used to treat bile duct stones and evaluate biliary strictures. Endoscopic fistula closure is discussed as a way to close gastrointestinal perforations. Endoscopic mucosal resection and endoscopic submucosal dissection are described as minimally invasive techniques to remove benign and early malignant lesions. Upper endoscopy and colonoscopy are summarized as procedures to examine the upper and lower gastrointestinal tract respectively. Potential risks associated with these endoscopic procedures include sedation side effects, bleeding, perforation, and infection.
This document discusses renal function tests and their use in evaluating kidney function. It describes the key functions of the kidney including fluid balance, waste excretion, blood pressure regulation, vitamin D and erythropoietin production. Tests are classified as evaluating glomerular function like glomerular filtration rate (GFR) tests or tubular function. GFR is best measured by creatinine clearance or equations using creatinine, age, and other factors. Urine and blood tests can indicate glomerular or tubular dysfunction. Clearance tests measure the removal of substances from blood by the kidneys. Renal biopsy may be used to diagnose kidney disease when function tests are unclear.
Renal biopsy is a procedure to obtain small pieces of kidney tissue for examination under a microscope. It provides valuable information about kidney disease by determining the cause, severity, and best treatment. Indications for renal biopsy include nephrotic syndrome, kidney disease with a systemic condition, acute kidney failure, and in renal transplants. Complications can include bleeding, pain, and fistula formation, but are generally rare. The biopsy results help establish a diagnosis and guide management of kidney disorders.
The document discusses various diagnostic tests involving visualization of body structures and functions. It describes procedures like endoscopy, colonoscopy and sigmoidoscopy which allow direct visualization of the gastrointestinal tract. Indirect visualization is achieved through radiographic imaging using barium and fluoroscopy. Procedures for visualizing the urinary system like IV pyelogram, cystoscopy and renal ultrasonography are also outlined. The document also discusses various cardiac diagnostic tests including electrocardiography, echocardiogram, stress testing and angiography. Visualization of the lungs can be achieved through procedures like bronchoscopy.
A kidney transplant involves surgically removing a healthy kidney from a living or deceased donor and implanting it into a recipient with kidney failure. The recipient must take lifelong immunosuppressive drugs to prevent rejection of the new organ. Complications can include infection, cardiovascular issues, and cancer due to immunosuppression. Care after transplant focuses on monitoring for signs of rejection like changes in urine output or kidney function tests and treating rejection promptly if it occurs. Long term management also involves managing side effects of immunosuppressants and screening for related health issues.
Coronary angiography is an x-ray examination of the heart's blood vessels. A small tube called a catheter is inserted into a blood vessel in the groin or arm and guided to the heart. A contrast dye is injected through the catheter to make the blood vessels visible on x-rays called angiograms. Preparation for coronary angiography involves explaining the procedure to the patient, obtaining consent, checking blood work and vital signs, preparing the insertion site, and providing psychological support and pre-medication. During the procedure, the patient's position and hemodynamics are monitored and contrast is injected to visualize the coronary arteries. Afterward, the sheath is removed, the site is dressed, and the patient is monitored
Cardiac biomarkers provide information about heart damage and heart failure. Commonly used cardiac biomarkers include creatine kinase-MB (CK-MB), myoglobin, cardiac troponins, and natriuretic peptides.
CK-MB and myoglobin levels begin to rise earlier than cardiac troponins after a heart attack, but they are less specific to the heart. Cardiac troponins are now the gold standard biomarkers for detecting myocardial injury since they remain elevated for longer and are highly specific to the heart.
Natriuretic peptides indicate heart failure and volume overload of the heart. Together, cardiac biomarkers can provide information about myocardial injury, ischemia, heart failure, and prognosis when clinical assessment is inconclusive
The document discusses resistant hypertension, defined as blood pressure above goal despite treatment with 3 or more antihypertensive drugs including a diuretic. Resistant hypertension affects up to 20% of hypertensive patients and increases cardiovascular risk. Causes include primary factors like age and secondary factors like primary aldosteronism. Pseudo-resistance can occur if measurements are inaccurate. Diagnosis requires excluding pseudo-resistance and investigating for reversible causes. Treatment involves lifestyle changes, adding additional drugs like spironolactone, or device therapies such as renal denervation or baroreflex activation. Target organ damage is common and includes left ventricular hypertrophy and kidney disease.
Liver function tests (LFTs) are biochemical blood tests that are useful for detecting and monitoring liver diseases. Common LFTs examine levels of serum albumin, globulin, bilirubin, and liver enzymes. Elevated levels of certain enzymes like ALT and AST indicate liver cell damage, while increased alkaline phosphatase or globulins may point to obstruction or inflammation. Together, LFT results can help diagnose liver problems, distinguish between disease types, and gauge treatment effectiveness. LFTs are among the most frequently performed medical lab tests.
The document provides information on the various colored blood collection tubes used in laboratories, including their common tests and proper usage. It discusses the purple, pink, blue, yellow, grey, red, dark green, and light green tubes, listing their additives, most common tests, and tips for proper collection techniques. While laboratory preferences may vary, this provides guidance on matching tests to the correct anticoagulated tube.
The document discusses renal function tests (RFTs). It provides information on:
- The functions of the kidney including homeostasis, excretion, and hormonal functions.
- Common RFTs including urine analysis, serum creatinine, BUN, eGFR, and cystatin C. These tests are used to evaluate glomerular filtration rate and detect kidney problems.
- Additional details are given on clearance tests using inulin, creatinine and urea to estimate GFR. Urine analysis and tests of tubular function are also summarized.
The document discusses various inotropic agents used to increase the force of cardiac muscle contractions including cardiac glycosides like digoxin, sympathomimetic drugs such as epinephrine, dopamine, and dobutamine, and phosphodiesterase inhibitors like amrinone. It provides details on the mechanisms of action, dosages, administration, and side effects of these different classes of inotropic drugs used to enhance cardiac contractility and output in patients with heart failure or shock.
A 59-year-old man presented to the emergency department with vomiting blood and loose black stool. He had a history of hypertension, hepatitis C, smoking, and alcohol use. Physical examination found distension of the abdomen with positive shifting dullness. Laboratory tests showed signs of liver dysfunction. Endoscopy revealed esophageal varices as the likely cause of bleeding given the patient's risk factors of liver disease. He was admitted and treated with fluid resuscitation, blood transfusion, and balloon tamponade to stop the bleeding from his esophageal varices which developed due to cirrhosis and portal hypertension.
The document discusses the functions and tests of the kidney. It notes that the kidney excretes waste, maintains water and electrolyte balance, and produces hormones. It describes renal clearance tests to assess glomerular and tubular function, including creatinine clearance and urine concentration tests. Normal ranges are provided for various blood and urine parameters. Renal function tests evaluate glomerular filtration rate and tubular function.
Fasting blood sugar readings refer to the amount of glucose present in the blood of diabetics prior ...
Read more at: http://www.living-healthy-with-diabetes.com/fasting-blood-sugar.html
AKI is a common problem in ICU patients, occurring in up to 18% of hospitalized patients with normal kidney function. Risk factors include conditions that reduce blood flow to the kidneys like sepsis or hypotension. The kidneys are vulnerable to toxins and drugs due to their high blood flow and the tubules' role in reabsorbing and secreting materials. Early detection of AKI using markers like serum creatinine and urine output is important for management, which aims to treat the underlying cause, ensure proper fluid balance and nutrition, and consider renal replacement therapy for severe cases.
The urinalysis provides important diagnostic information through gross assessment, dipstick analysis, and microscopic examination of urine sediment. Gross assessment evaluates color, clarity, and other physical characteristics. Dipstick analysis rapidly tests for substances like hematuria, protein, glucose, and nitrites. Microscopic sediment examination identifies cells and casts that can indicate conditions like urinary tract infection or glomerular disease. Together, a complete urinalysis gives valuable clues for evaluating kidney function and identifying underlying renal or systemic disorders.
This case study describes the care of a 63-year-old man with diabetes mellitus and hypertension. The patient presented with dizziness and weakness. Through history taking, examinations, and investigations, it was found that the patient had poorly controlled blood sugar and hypertension. He was provided treatment including insulin therapy, medication to control his blood pressure, dietary advice, and education on self-management. The case study helped provide knowledge about diabetes, its treatment, nursing care, and potential complications.
This document contains a nursing care plan for a 49-year-old male patient diagnosed with diabetes mellitus with diabetic ketoacidosis, hypotension, and L5 radiculopathy. It includes the patient's medical history, physical examination findings, lab and imaging results, medications, and definitions related to diabetes. The physical exam found the patient to have dry skin, increased vital signs, decreased muscle strength and range of motion in the right lower limb, and back pain radiating to the right leg. Lab tests showed hyperglycemia, poor diabetic control, hyperlipidemia, and signs of DKA. The patient has been prescribed insulin and oral medications to manage his diabetes and related conditions.
1) Abdominal paracentesis is a procedure where a needle is inserted into the peritoneal cavity to remove ascitic fluid. It can be performed for diagnostic purposes to obtain a small fluid sample for testing or therapeutically to remove over 5 liters of fluid.
2) The optimal site for paracentesis is the left lower quadrant of the abdomen to access the thicker abdominal wall and larger fluid pool. Ultrasound guidance can be used.
3) After marking the skin and administering local anesthesia using the "Z-track" technique, the needle is slowly inserted while aspirating to check for blood. Fluid flow indicates proper needle placement in the peritoneal cavity.
A 65-year-old male with a history of diabetes was admitted with shortness of breath, palpitations, and urinary frequency. Coronary angiography revealed mild coronary artery disease with triple vessel involvement. He was diagnosed with coronary artery disease (CAD) likely caused by his diabetes. He was treated medically with drugs including furosemide, digoxin, heparin, clopidogrel, glimepiride, and metformin. The goals of treatment were to alter disease progression, reduce complications, and manage symptoms through lifestyle modifications and pharmacological therapy.
learn how to obtain an ECG, anyone can do it:
This presentation aims to show the clinical process of obtaining an ECG and features some tips and suggestions to troubleshoot and improve the quality of the tracing.
Please note that you're welcome to use any slides as long as you reference my post when you do so to maintain the integrity of authorship
If interested in detailed answers, please email: aamirdash@yahoo.com
Thanks, Ahmad
This document discusses various diagnostic procedures used to investigate respiratory diseases. It describes noninvasive procedures like radiographic imaging, sputum examination and pulmonary function tests. Invasive procedures discussed include skin tests, blood gas analysis and thoracentesis. Specialized procedures like bronchoscopy, thoracoscopy and lung biopsy are also outlined. Details are provided on specific radiographic techniques, interpreting chest X-rays, and indications for CT scans and MRI. Procedures for blood gas analysis and thoracentesis are summarized.
This document provides information on hemodialysis catheters. It begins by describing the characteristics of an ideal catheter and then discusses permacath catheters, which are tunnelled central venous catheters often used for hemodialysis. The document outlines the advantages and disadvantages of catheters compared to arteriovenous fistulas. It also discusses various complications associated with catheters including thrombosis, fibrin sheath formation, infection, and vascular thrombosis. The document provides details on preventing, diagnosing, and treating these complications.
Colostomy is a surgically created open in the colon for the purpose of evacuation of bowel.
Colostomy care is the maintenance of hygiene by regular emptying of colostomy bag and cleaning colostomy site.
Laboratory diagnostic tests are important tools for clinicians to obtain additional information about a patient's status beyond a physical exam and history. Tests are used for screening, diagnosis, monitoring treatment response, and evaluating disease severity. Common tests include complete blood count, lipid profile, blood sugars, liver function tests, urine analysis, and pregnancy testing. Proper specimen collection and handling is important to obtain accurate results. Clinicians must explain the purpose and implications of tests to patients.
Cardiac biomarkers provide information about heart damage and heart failure. Commonly used cardiac biomarkers include creatine kinase-MB (CK-MB), myoglobin, cardiac troponins, and natriuretic peptides.
CK-MB and myoglobin levels begin to rise earlier than cardiac troponins after a heart attack, but they are less specific to the heart. Cardiac troponins are now the gold standard biomarkers for detecting myocardial injury since they remain elevated for longer and are highly specific to the heart.
Natriuretic peptides indicate heart failure and volume overload of the heart. Together, cardiac biomarkers can provide information about myocardial injury, ischemia, heart failure, and prognosis when clinical assessment is inconclusive
The document discusses resistant hypertension, defined as blood pressure above goal despite treatment with 3 or more antihypertensive drugs including a diuretic. Resistant hypertension affects up to 20% of hypertensive patients and increases cardiovascular risk. Causes include primary factors like age and secondary factors like primary aldosteronism. Pseudo-resistance can occur if measurements are inaccurate. Diagnosis requires excluding pseudo-resistance and investigating for reversible causes. Treatment involves lifestyle changes, adding additional drugs like spironolactone, or device therapies such as renal denervation or baroreflex activation. Target organ damage is common and includes left ventricular hypertrophy and kidney disease.
Liver function tests (LFTs) are biochemical blood tests that are useful for detecting and monitoring liver diseases. Common LFTs examine levels of serum albumin, globulin, bilirubin, and liver enzymes. Elevated levels of certain enzymes like ALT and AST indicate liver cell damage, while increased alkaline phosphatase or globulins may point to obstruction or inflammation. Together, LFT results can help diagnose liver problems, distinguish between disease types, and gauge treatment effectiveness. LFTs are among the most frequently performed medical lab tests.
The document provides information on the various colored blood collection tubes used in laboratories, including their common tests and proper usage. It discusses the purple, pink, blue, yellow, grey, red, dark green, and light green tubes, listing their additives, most common tests, and tips for proper collection techniques. While laboratory preferences may vary, this provides guidance on matching tests to the correct anticoagulated tube.
The document discusses renal function tests (RFTs). It provides information on:
- The functions of the kidney including homeostasis, excretion, and hormonal functions.
- Common RFTs including urine analysis, serum creatinine, BUN, eGFR, and cystatin C. These tests are used to evaluate glomerular filtration rate and detect kidney problems.
- Additional details are given on clearance tests using inulin, creatinine and urea to estimate GFR. Urine analysis and tests of tubular function are also summarized.
The document discusses various inotropic agents used to increase the force of cardiac muscle contractions including cardiac glycosides like digoxin, sympathomimetic drugs such as epinephrine, dopamine, and dobutamine, and phosphodiesterase inhibitors like amrinone. It provides details on the mechanisms of action, dosages, administration, and side effects of these different classes of inotropic drugs used to enhance cardiac contractility and output in patients with heart failure or shock.
A 59-year-old man presented to the emergency department with vomiting blood and loose black stool. He had a history of hypertension, hepatitis C, smoking, and alcohol use. Physical examination found distension of the abdomen with positive shifting dullness. Laboratory tests showed signs of liver dysfunction. Endoscopy revealed esophageal varices as the likely cause of bleeding given the patient's risk factors of liver disease. He was admitted and treated with fluid resuscitation, blood transfusion, and balloon tamponade to stop the bleeding from his esophageal varices which developed due to cirrhosis and portal hypertension.
The document discusses the functions and tests of the kidney. It notes that the kidney excretes waste, maintains water and electrolyte balance, and produces hormones. It describes renal clearance tests to assess glomerular and tubular function, including creatinine clearance and urine concentration tests. Normal ranges are provided for various blood and urine parameters. Renal function tests evaluate glomerular filtration rate and tubular function.
Fasting blood sugar readings refer to the amount of glucose present in the blood of diabetics prior ...
Read more at: http://www.living-healthy-with-diabetes.com/fasting-blood-sugar.html
AKI is a common problem in ICU patients, occurring in up to 18% of hospitalized patients with normal kidney function. Risk factors include conditions that reduce blood flow to the kidneys like sepsis or hypotension. The kidneys are vulnerable to toxins and drugs due to their high blood flow and the tubules' role in reabsorbing and secreting materials. Early detection of AKI using markers like serum creatinine and urine output is important for management, which aims to treat the underlying cause, ensure proper fluid balance and nutrition, and consider renal replacement therapy for severe cases.
The urinalysis provides important diagnostic information through gross assessment, dipstick analysis, and microscopic examination of urine sediment. Gross assessment evaluates color, clarity, and other physical characteristics. Dipstick analysis rapidly tests for substances like hematuria, protein, glucose, and nitrites. Microscopic sediment examination identifies cells and casts that can indicate conditions like urinary tract infection or glomerular disease. Together, a complete urinalysis gives valuable clues for evaluating kidney function and identifying underlying renal or systemic disorders.
This case study describes the care of a 63-year-old man with diabetes mellitus and hypertension. The patient presented with dizziness and weakness. Through history taking, examinations, and investigations, it was found that the patient had poorly controlled blood sugar and hypertension. He was provided treatment including insulin therapy, medication to control his blood pressure, dietary advice, and education on self-management. The case study helped provide knowledge about diabetes, its treatment, nursing care, and potential complications.
This document contains a nursing care plan for a 49-year-old male patient diagnosed with diabetes mellitus with diabetic ketoacidosis, hypotension, and L5 radiculopathy. It includes the patient's medical history, physical examination findings, lab and imaging results, medications, and definitions related to diabetes. The physical exam found the patient to have dry skin, increased vital signs, decreased muscle strength and range of motion in the right lower limb, and back pain radiating to the right leg. Lab tests showed hyperglycemia, poor diabetic control, hyperlipidemia, and signs of DKA. The patient has been prescribed insulin and oral medications to manage his diabetes and related conditions.
1) Abdominal paracentesis is a procedure where a needle is inserted into the peritoneal cavity to remove ascitic fluid. It can be performed for diagnostic purposes to obtain a small fluid sample for testing or therapeutically to remove over 5 liters of fluid.
2) The optimal site for paracentesis is the left lower quadrant of the abdomen to access the thicker abdominal wall and larger fluid pool. Ultrasound guidance can be used.
3) After marking the skin and administering local anesthesia using the "Z-track" technique, the needle is slowly inserted while aspirating to check for blood. Fluid flow indicates proper needle placement in the peritoneal cavity.
A 65-year-old male with a history of diabetes was admitted with shortness of breath, palpitations, and urinary frequency. Coronary angiography revealed mild coronary artery disease with triple vessel involvement. He was diagnosed with coronary artery disease (CAD) likely caused by his diabetes. He was treated medically with drugs including furosemide, digoxin, heparin, clopidogrel, glimepiride, and metformin. The goals of treatment were to alter disease progression, reduce complications, and manage symptoms through lifestyle modifications and pharmacological therapy.
learn how to obtain an ECG, anyone can do it:
This presentation aims to show the clinical process of obtaining an ECG and features some tips and suggestions to troubleshoot and improve the quality of the tracing.
Please note that you're welcome to use any slides as long as you reference my post when you do so to maintain the integrity of authorship
If interested in detailed answers, please email: aamirdash@yahoo.com
Thanks, Ahmad
This document discusses various diagnostic procedures used to investigate respiratory diseases. It describes noninvasive procedures like radiographic imaging, sputum examination and pulmonary function tests. Invasive procedures discussed include skin tests, blood gas analysis and thoracentesis. Specialized procedures like bronchoscopy, thoracoscopy and lung biopsy are also outlined. Details are provided on specific radiographic techniques, interpreting chest X-rays, and indications for CT scans and MRI. Procedures for blood gas analysis and thoracentesis are summarized.
This document provides information on hemodialysis catheters. It begins by describing the characteristics of an ideal catheter and then discusses permacath catheters, which are tunnelled central venous catheters often used for hemodialysis. The document outlines the advantages and disadvantages of catheters compared to arteriovenous fistulas. It also discusses various complications associated with catheters including thrombosis, fibrin sheath formation, infection, and vascular thrombosis. The document provides details on preventing, diagnosing, and treating these complications.
Colostomy is a surgically created open in the colon for the purpose of evacuation of bowel.
Colostomy care is the maintenance of hygiene by regular emptying of colostomy bag and cleaning colostomy site.
Laboratory diagnostic tests are important tools for clinicians to obtain additional information about a patient's status beyond a physical exam and history. Tests are used for screening, diagnosis, monitoring treatment response, and evaluating disease severity. Common tests include complete blood count, lipid profile, blood sugars, liver function tests, urine analysis, and pregnancy testing. Proper specimen collection and handling is important to obtain accurate results. Clinicians must explain the purpose and implications of tests to patients.
This document provides an overview of various laboratory investigations that are important for oral and maxillofacial surgeons. It summarizes hematological investigations including complete blood count, coagulation tests, and biochemical investigations like lipid profile, glucose, kidney/liver function tests. It describes the purpose and clinical significance of these common blood tests and their normal ranges.
The document discusses the interpretation of a complete blood count (CBC) test. A CBC provides information on red blood cells, white blood cells, and platelets. Abnormal CBC results can indicate conditions like infections, anemias, leukemias, and other disorders. The document outlines normal CBC reference ranges and provides guidance on interpreting abnormal high or low blood cell counts based on the specific cell type affected and considering the clinical context.
This document provides information on how to read a complete blood count (CBC). It defines a CBC as a series of blood tests that evaluate the cellular components of blood. The CBC measures red blood cell count, white blood cell count, hemoglobin, hematocrit, and platelet count. It also provides indices to characterize red blood cells, such as mean corpuscular volume. The summary discusses the clinical implications of abnormalities in these values, such as indicating infection or anemia.
This document discusses hematological investigations that are useful in clinical dentistry. It begins by explaining that laboratory studies provide information to identify the nature of diseases by examining tissues, blood, and other specimens. Some key points covered include:
- Laboratory tests can confirm or reject clinical diagnoses and provide guidance for patient management.
- Tests are classified as screening or diagnostic based on their sensitivity and specificity.
- Common hematological investigations performed include complete blood count, hemoglobin analysis, and coagulation tests.
- Proper collection and preservation of blood samples is important for accurate test results.
So in summary, the document outlines the role of laboratory hematological tests in clinical dentistry for diagnosing systemic conditions and
Blood is a circulating fluid composed of plasma, red blood cells, white blood cells, and platelets. It transports nutrients, oxygen, waste, and immune cells throughout the body. Blood transfusions may be used to treat blood loss or deficiencies, with risks including allergic reactions, fever, and rare but serious immune reactions if the blood types are incompatible. Proper identification, consent, ordering, and monitoring procedures are required for safe transfusion.
Clinical laboratory test results are very important for diagnosis, monitoring, and screening. 70-80% of diagnostic decisions are based on laboratory results. Thus, it is imperative that clinicians understand laboratory tests and how to properly interpret results. Laboratory results must be interpreted using reference intervals that distinguish health from disease states. Clinicians must consider biological variation and the potential for false positive or negative results. The laboratory also has a responsibility to provide clinicians with information to assist in correct interpretation.
It is also called as complete blood picture/complete blood count(CBP/CBC)
The FBC assesses several different parameters and can provide a great deal of information.
The red cell variables will determine whether or not the patient is anaemic. If anaemia is present the MCV is likely to provide clues as to the cause of the anaemia.
The white cells are often raised in infection neutrophilia in bacterial infections and lymphocytosis in viral (but not always so).
Platelets (size or number) may be abnormal either as a direct effect of underlying blood disease.
This document discusses clinical laboratory tests used to evaluate disease states, including a complete blood count (CBC). A CBC assesses red blood cell, white blood cell, and platelet parameters to detect anemias and infections. Red cell count, hemoglobin, hematocrit, mean corpuscular volume (MCV) are used to classify anemias as microcytic, normocytic, or macrocytic. White cell differential counts of neutrophils, lymphocytes, monocytes, eosinophils and basophils provide clues about bacterial vs. viral infections. Abnormal CBC results can indicate conditions like iron deficiency anemia, thalassemia, polycythemia, or leukemia. The document provides reference ranges and discusses abnormalities
Interpretation of clinical laboratory values.pptxNathanGospel
Laboratory tests are performed to discover, diagnose, stage or classify diseases, and monitor therapy effectiveness. Tests are classified as screening or diagnostic. Pharmacists monitor laboratory tests to assess drug effects, determine proper dosing, and assess need for alternative therapy. Common tests include complete blood count, liver and kidney function tests, and cardiac enzyme levels. Abnormal results can indicate various diseases and conditions. Proper interpretation requires considering patient factors and potential sources of error.
A complete blood count (CBC) is a series of blood tests that evaluates the concentration and composition of blood cells. A CBC provides information about red blood cell count, white blood cell count, platelet count, hemoglobin, hematocrit, and cell morphology. Abnormal cell counts may indicate diseases like infections, blood disorders, or cancers. A CBC is used to monitor overall health, screen for diseases, confirm diagnoses, and monitor medical treatments. It provides information on acute or chronic medical conditions.
This chapter discusses cell counts on cerebrospinal fluid (CSF) and other body fluids. It defines CSF as the fluid surrounding the brain and spinal cord, and outlines its role in protecting and nourishing the central nervous system. The chapter describes how to perform total and differential white blood cell counts on CSF and other fluids like pleural fluid. It provides normal ranges for cell counts in CSF and explains how elevated counts may indicate conditions like meningitis or hemorrhage. The chapter also discusses potential sources of error and quality control measures for accurate body fluid analysis.
Laboratory Investigation particular for Dentistry.pptxDr. Dhruvi Shah
This document provides information about laboratory investigations in oral medicine and radiology. It defines laboratory investigations as examinations of tissues, blood, urine or other specimens under a microscope, or using biochemical, microbiological, or immunological techniques. It then classifies laboratory investigations as chairside tests or those done in a laboratory, and groups them based on location, sensitivity/specificity, or whether they are clinical or surgical. The document focuses on the importance of blood in laboratory tests and provides details about complete blood count tests, including red blood cell counts and indices, white blood cell counts and differentials, platelet counts, and other qualitative assessments. It describes blood collection methods and the clinical significance of abnormalities in test results.
1. The document discusses various factors that can affect the accuracy of blood cell counts from hematology analyzers, including lipemia, sickle cells, and the presence of nucleated red blood cells.
2. It provides methods for correcting blood count results when issues like lipemia or nucleated red blood cells are present, such as saline replacement or subtracting nucleated red blood cells from the white blood cell count.
3. Normal variations in white blood cell, red blood cell, and platelet counts are discussed for different times of day, during exercise or pregnancy, and with factors like altitude.
A complete blood count (CBC) is a blood test that evaluates the components and concentration of cells in the blood. It provides information on red blood cell count, white blood cell count, hematocrit level, hemoglobin, and platelet count. Abnormal cell counts may indicate health issues like infections, bleeding disorders, or cancers. A CBC is performed to screen for diseases, confirm diagnoses, and monitor medical treatments by reflecting health conditions that could affect the cellular components of blood. It measures components like red blood cell count, hemoglobin level, hematocrit, and mean corpuscular volume to help identify anemias, infections, and other medical conditions.
Investigations in hemorrhegic disorders ppt Prashant MunePrashant Munde
Clinical assessment, pertinent history, and family history are good indicators for determining patient's bleeding tendencies.
The most appropriate laboratory tests performed are Routine screening tests include a complete blood cell count, platelet count, and evaluation of a peripheral blood sample, a prothrombin time, and an activated partial thromboplastin time.
Kinetic studies on malachite green dye adsorption from aqueous solutions by A...Open Access Research Paper
Water polluted by dyestuffs compounds is a global threat to health and the environment; accordingly, we prepared a green novel sorbent chemical and Physical system from an algae, chitosan and chitosan nanoparticle and impregnated with algae with chitosan nanocomposite for the sorption of Malachite green dye from water. The algae with chitosan nanocomposite by a simple method and used as a recyclable and effective adsorbent for the removal of malachite green dye from aqueous solutions. Algae, chitosan, chitosan nanoparticle and algae with chitosan nanocomposite were characterized using different physicochemical methods. The functional groups and chemical compounds found in algae, chitosan, chitosan algae, chitosan nanoparticle, and chitosan nanoparticle with algae were identified using FTIR, SEM, and TGADTA/DTG techniques. The optimal adsorption conditions, different dosages, pH and Temperature the amount of algae with chitosan nanocomposite were determined. At optimized conditions and the batch equilibrium studies more than 99% of the dye was removed. The adsorption process data matched well kinetics showed that the reaction order for dye varied with pseudo-first order and pseudo-second order. Furthermore, the maximum adsorption capacity of the algae with chitosan nanocomposite toward malachite green dye reached as high as 15.5mg/g, respectively. Finally, multiple times reusing of algae with chitosan nanocomposite and removing dye from a real wastewater has made it a promising and attractive option for further practical applications.
Earth Day How has technology changed our life?
Thinkers/Inquiry • How has our ability to think and inquire helped to advance technology?
Vocabulary • Nature Deficit Disorder~ A condition that some people maintain is a spreading affliction especially affecting youth but also their adult counterparts, characterized by an excessive lack of familiarity with the outdoors and the natural world. • Precautionary Principle~ The approach whereby any possible risk associated with the introduction of a new technology is largely avoided, until a full understanding of its impact on health, environment and other areas is available.
What is technology? • Brainstorm a list of technology that you use everyday that your parents or grandparents did not have. • Compare your list with a partner.
Evolving Lifecycles with High Resolution Site Characterization (HRSC) and 3-D...Joshua Orris
The incorporation of a 3DCSM and completion of HRSC provided a tool for enhanced, data-driven, decisions to support a change in remediation closure strategies. Currently, an approved pilot study has been obtained to shut-down the remediation systems (ISCO, P&T) and conduct a hydraulic study under non-pumping conditions. A separate micro-biological bench scale treatability study was competed that yielded positive results for an emerging innovative technology. As a result, a field pilot study has commenced with results expected in nine-twelve months. With the results of the hydraulic study, field pilot studies and an updated risk assessment leading site monitoring optimization cost lifecycle savings upwards of $15MM towards an alternatively evolved best available technology remediation closure strategy.
Monitor indicators of genetic diversity from space using Earth Observation dataSpatial Genetics
Genetic diversity within and among populations is essential for species persistence. While targets and indicators for genetic diversity are captured in the Kunming-Montreal Global Biodiversity Framework, assessing genetic diversity across many species at national and regional scales remains challenging. Parties to the Convention on Biological Diversity (CBD) need accessible tools for reliable and efficient monitoring at relevant scales. Here, we describe how Earth Observation satellites (EO) make essential contributions to enable, accelerate, and improve genetic diversity monitoring and preservation. Specifically, we introduce a workflow integrating EO into existing genetic diversity monitoring strategies and present a set of examples where EO data is or can be integrated to improve assessment, monitoring, and conservation. We describe how available EO data can be integrated in innovative ways to support calculation of the genetic diversity indicators of the GBF monitoring framework and to inform management and monitoring decisions, especially in areas with limited research infrastructure or access. We also describe novel, integrative approaches to improve the indicators that can be implemented with the coming generation of EO data, and new capabilities that will provide unprecedented detail to characterize the changes to Earth’s surface and their implications for biodiversity, on a global scale.
Optimizing Post Remediation Groundwater Performance with Enhanced Microbiolog...Joshua Orris
Results of geophysics and pneumatic injection pilot tests during 2003 – 2007 yielded significant positive results for injection delivery design and contaminant mass treatment, resulting in permanent shut-down of an existing groundwater Pump & Treat system.
Accessible source areas were subsequently removed (2011) by soil excavation and treated with the placement of Emulsified Vegetable Oil EVO and zero-valent iron ZVI to accelerate treatment of impacted groundwater in overburden and weathered fractured bedrock. Post pilot test and post remediation groundwater monitoring has included analyses of CVOCs, organic fatty acids, dissolved gases and QuantArray® -Chlor to quantify key microorganisms (e.g., Dehalococcoides, Dehalobacter, etc.) and functional genes (e.g., vinyl chloride reductase, methane monooxygenase, etc.) to assess potential for reductive dechlorination and aerobic cometabolism of CVOCs.
In 2022, the first commercial application of MetaArray™ was performed at the site. MetaArray™ utilizes statistical analysis, such as principal component analysis and multivariate analysis to provide evidence that reductive dechlorination is active or even that it is slowing. This creates actionable data allowing users to save money by making important site management decisions earlier.
The results of the MetaArray™ analysis’ support vector machine (SVM) identified groundwater monitoring wells with a 80% confidence that were characterized as either Limited for Reductive Decholorination or had a High Reductive Reduction Dechlorination potential. The results of MetaArray™ will be used to further optimize the site’s post remediation monitoring program for monitored natural attenuation.
2. Complete blood count
The complete blood count (CBC) is a group of tests that
evaluate the cells that circulate in blood, including
Red blood cells (RBCs).
White blood cells (WBCs).
Platelets (PLTs).
3. Complete blood count - WBC
Description
A WBC count, also called a leukocyte count, is part of a
complete blood count.
It indicates the number of white cells in a microliter (μL, or
cubic millimeter) of whole blood.
WBC counts may vary by as much as 2000 cells/μL (SI, 2 ×
109/L) on any given day due to strenuous exercise, stress, or
digestion.
The WBC count may increase or decrease significantly in
certain diseases, but it’s diagnostically useful only when the
patient’s white cell differential and clinical status are
considered.
4. Complete blood count - WBC
Description
The WBC differential is used to evaluate the distribution and
morphology of WBCs, providing more specific information about a
patient’s immune system than a WBC count alone.
WBCs are classified as one of five major types of leukocytes—
neutrophils, eosinophils, basophils, lymphocytes, and monocytes—
and the percentage of each type is determined.
The differential count is the percentage of each type of WBC in the
blood. The total number of each WBC type is obtained by
multiplying its percentage by the total WBC count.
5. Complete blood count-WBC
Purpose
To determine infection or inflammation
To determine the need for further tests such as bone marrow
biopsy.
To monitor response to chemotherapy or radiation therapy
6. Complete blood count - WBC
Purpose-WBC Differential
To evaluate the body’s capacity to resist and overcome
infection.
To detect and identify various types of leukemia.
To determine the stage and severity of an infection.
To detect allergic reactions and parasitic infections and
assess their severity
To distinguish viral from bacterial infections
7. Complete blood count - WBC
Reference Values
4000 to 10,000/μL (SI, 4 to 10 × 109/L).
For an accurate diagnosis, differential test results always
must be interpreted in relation to the total white blood cell
(WBC) count.
9. Complete blood count - WBC
Elevated Levels- Nursing Implications
Report any abnormal findings to the practitioner.
Prepare to educate the patient about his diagnosis.
Prepare the patient for further testing or surgery, as indicated.
Provide emotional support to the patient and his family.
Prepare to administer antimicrobial therapy as indicated.
Institute isolation precautions as applicable
10. Complete blood count - WBC
Abnormal Findings- Decreased Levels (Leukopenia)
Bone marrow depression
Viral infections
Ingestion of mercury or other heavy metals
Exposure to benzene or arsenicals
Influenza
Typhoid fever
Measles
Infectious hepatitis
11. Complete blood count - WBC
Decreased Levels- Nursing Implications
Report any abnormal findings to the practitioner.
Prepare to educate the patient about his diagnosis.
Prepare the patient for further testing or surgery, as indicated.
Provide emotional support to the patient and his family.
Prepare to administer antimicrobial therapy as indicated.
Institute isolation precautions as applicable.
12. Complete blood count - WBC
Interfering Factors
WBC Count
Digestion, exercise, or stress
Anticonvulsants, such as phenytoin derivatives; nonsteroidal
anti-inflammatory drugs such as indomethacin (Indocin); and
thyroid hormone antagonists (decrease).
Precautions
Completely fill the sample collection tube.
Invert the sample gently several times to mix the sample and
the anticoagulant.
13. Complete blood count - WBC
Nursing Considerations- Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the WBC count and differential test
is used to detect an infection or inflammation (WBC count) or
evaluate the immune system (WBC differential).
Advise the patient that a blood sample will be taken. Explain
that he may feel slight discomfort from the tourniquet and
needle puncture.
14. Complete blood count - WBC
Nursing Considerations- Before the Test
Inform the patient that he doesn’t need to restrict food and
fluids but that he should avoid strenuous exercise for 24
hours before the test. Also tell him that he should avoid eating
a heavy meal before the test.
If the patient is being treated for an infection, advise him that
this test will be repeated to monitor his progress.
Notify the laboratory and physician of medications the patient
is taking that may affect test results; they may need to be
restricted
15. Complete blood count - WBC
After the Test
If a hematoma develops at the venipuncture site, apply pressure. If
the hematoma is large, monitor pulses distal to the venipuncture
site.
Instruct the patient that he may resume his usual diet, activity, and
medications discontinued before the test, as ordered.
Be aware that a patient with severe leukopenia may have little or
no resistance to infection and requires infection control
precautions.
16. Complete blood count-RBC
Description
The RBC count, also called an erythrocyte count, is part of a
complete blood count.
It’s used to detect the number of RBCs in a microliter (μL) or
cubic millimeter (mm3), of whole blood.
The RBC count itself provides no qualitative information
regarding the size, shape, or concentration of Hb within the
corpuscles, but it may be used to calculate two erythrocyte
indices:
o Mean corpuscular volume (MCV)
o Mean corpuscular hemoglobin (MCH)
17. Complete blood count-RBC
Purpose
To provide data for calculating mean corpuscular volume
(MCV) and mean corpuscular hemoglobin (MCH), which
reveal RBC size and hemoglobin (Hb) content.
To support other hematologic tests for diagnosing anemia or
polycythemia.
18. Complete blood count-RBC
Reference Values
Adult females: 4 to 5 million red blood cells (RBCs)/μL (SI, 4
to 5 × 1012/L) of venous blood
Adult males: 4.5 to 5.5 million RBCs/ μL (SI, 4.5 to 5.5 ×
1012/L) of venous blood
19. Complete blood count-RBC
Abnormal Findings- Elevated Levels
Absolute or relative polycythemia
Nursing Implications
Report abnormal findings to the practitioner.
Prepare to educate the patient about his diagnosis.
Prepare the patient for further testing as indicated.
20. Complete blood count-RBC
Abnormal Findings - Decreased Levels
Anemia
Dilution caused by fluid overload
Hemorrhage beyond 24 hours
Nursing Implications
Report abnormal findings to the practitioner.
Prepare to educate the patient about his diagnosis.
Prepare the patient for further testing as indicated.
21. Complete blood count-RBC
Interfering Factors
Hemoconcentration caused by prolonged tourniquet
constriction.
Hemodilution caused by drawing the sample from the same
arm used for IV fluid infusion
Diseases that cause RBCs to agglutinate or form rouleaux
(false decrease).
Hemolysis resulting from rough handling of the sample or
drawing the blood through a small-gauge needle for
venipuncture.
23. Complete blood count-RBC
Nursing Considerations-Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the RBC count is used to evaluate the
number of RBCs and to detect possible blood disorders.
Advise the patient that a blood sample will be taken. Explain that
he may feel slight discomfort from the tourniquet and needle
puncture.
Inform the patient that he doesn’t need to restrict food and fluids
for the test.
24. Complete blood count-RBC
During the Test
Fill the collection tube completely.
Invert the tube gently several times to mix the sample and the
anticoagulant.
After the Test
Apply pressure to the venipuncture site until bleeding stops.
If a hematoma develops at the venipuncture site, apply direct
pressure.
25. Complete blood count- Platelet Count
Description
Platelets, or thrombocytes, are the smallest formed elements
in blood.
They promote coagulation and the formation of a hemostatic
plug in vascular injury.
Platelet count is one of the most important screening tests of
platelet function. Accurate counts are vital.
26. Complete blood count-Platelet Count
Purpose
To evaluate platelet production.
To assess the effects of chemotherapy or radiation therapy on
platelet production.
To diagnose and monitor severe thrombocytosis or
thrombocytopenia.
27. Platelet Count
Reference Values
Adults: 140,000 to 400,000/μL (SI, 140 to 400 × 109/L)
Critical Values
Less than 50,000/μL (can cause spontaneous bleeding).
Less than 5000/μL (possible fatal central nervous system
bleeding or massive GI hemorrhage)
28. Platelet Count
Abnormal Findings- Elevated Levels (thrombocytosis)
Hemorrhage.
Infectious or inflammatory disorders
Iron deficiency anemia
Splenectomy or other recent surgery
Pregnancy
Chronic myelogenous leukemia
29. Platelet Count
Elevated Levels- Nursing Implications
Prepare the patient for additional testing, including a complete
blood count (CBC), bone marrow biopsy,
Report abnormal findings to the practitioner.
Prepare to educate the patient about his diagnosis
30. Platelet Count
Abnormal Findings-Decreased Levels
Splenectomy.
Leukemia.
Disseminated infection
Folic acid or vitamin B12 deficiency
Pooling of platelets in an enlarged spleen.
Increased platelet destruction caused by drugs or an immune
disorder
Disseminated intravascular coagulation
Mechanical injury to platelets
31. Platelet Count
Nursing Implications -Decreased Levels
(thrombocytopenia)
Prepare the patient for additional testing, including a CBC,
bone marrow biopsy, direct antiglobulin test (direct Coombs’
test), and serum protein electrophoresis.
Report abnormal findings to the practitioner.
Prepare to educate the patient about his diagnosis.
33. Platelet Count
Precautions
To prevent hemolysis, avoid excessive probing at the
venipuncture site and handle the sample gently.
Nursing Considerations- Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the platelet count test is used to
determine if the patient’s blood clots normally.
34. Platelet Count
Nursing Considerations- Before the Test
Advise the patient that a blood sample will be taken. Explain
that he may feel slight discomfort from the needle puncture
and the tourniquet.
Inform the patient that he doesn’t need to restrict food and
fluids for the test.
Notify the laboratory and practitioner of medications the
patient is taking that may affect test results; they may need to
be restricted.
35. Platelet Count
During the Test
Completely fill the collection tube and invert it gently several
times to mix the sample and the anticoagulant thoroughly.
After the Test
Apply pressure to the venipuncture site until bleeding has
stopped.
If a hematoma develops at the veni puncture site, apply direct
pressure. If the hematoma is large, monitor pulses distal to
the venipuncture site.
Tell the patient that he may resume any medications that were
discontinued before the test as ordered.
37. Blood Urea Nitrogen (BUN)
Description
The blood urea nitrogen (BUN) test is used to measure the
nitrogen fraction of urea, the chief end product of protein
metabolism.
urea Formed in the liver from ammonia and excreted by the
kidneys, urea constitutes 40% to 50% of the blood’s
nonprotein nitrogen content.
BUN level reflects protein intake and renal excretory capacity,
but it’s a less reliable indicator of uremia than the serum
creatinine level.
38. Blood Urea Nitrogen
Purpose
To evaluate kidney function and aid in the diagnosis of renal
disease
To aid in the assessment of hydration.
39. Blood Urea Nitrogen
Reference Values
8 to 20 mg/dL (SI, 2.9–7.5 mmol/L)
Elderly patients: slightly higher, possibly to 69 mg/dL (SI, 25.8
mmol/L.
Critical Values
Less than 2 mg/dL (SI, 0.71 mmol/L)
Greater than 80 mg/dL (SI, 2.85 mmol/L)
40. Blood Urea Nitrogen
Abnormal Findings- Elevated Levels
Renal disease (greater than 100 mg indicates serious
impairment of renal function).
Reduced renal blood flow (due to dehydration, for example).
Urinary tract obstruction.
Increased protein catabolism (such as with burns).
Nursing Implications
Prepare the patient for further testing.
Explain the underlying problem associated with the elevated
level.
41. Blood Urea Nitrogen
Decreased Levels
Severe hepatic damage.
Malnutrition
Overhydration
Nursing Implications
Prepare the patient for additional testing.
Institute measures, as ordered, to correct nutritional and fluid
imbalances.
42. Blood Urea Nitrogen
Interfering Factors
Chloramphenicol and tetracyclines (possible decrease)
Overhydration and underhydration will affect BUN levels
43. Blood Urea Nitrogen
Nursing Considerations-Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Tell the patient that the BUN test is used to evaluate kidney
function.
Inform the patient that he doesn’t need to restrict food and
fluids, but should limit his meat intake (protein intake affects
BUN levels).
Explain to the patient that the test requires a blood sample
from a venipuncture. Advise him that he may experience
slight discomfort from the tourniquet and needle puncture.
44. Blood Urea Nitrogen
After the Test
Handle the sample gently and send it to the laboratory
immediately.
Apply direct pressure to the venipuncture site until bleeding
stops.
Inform the patient that he may resume medications that were
discontinued before the test, as ordered
45. Creatinine, Serum
Description
Serum creatinine levels provide a more sensitive measure of
renal damage than do blood urea nitrogen levels.
Creatinine is a nonprotein end product of creatine metabolism
that appears in serum in amounts proportional to the body’s
muscle mass.
Purpose
To assess glomerular filtration
To screen for renal damage
46. Creatinine, Serum
Reference Values
Females: 0.6 to 0.9 mg/dL (SI, 53–97 μmol/L)
Males: 0.8 to 1.2 mg/dL (SI, 62–115 μmol/L)
Critical Values
Less than 0.4 mg/dL (SI, 35 μmol/L) or
More than 2.8 mg/dL (SI, 247 μmol/L)
47. Creatinine, Serum
Abnormal Findings- Elevated Levels
Plasma creatinine of 2 mg/dL indicates that renal disease has
seriously damaged 50% or more of the nephrons.
Gigantism and acromegaly.
Nursing Implications
Anticipate the need for additional testing.
Prepare the patient for follow-up and treatment.
Monitor fluid balance and intake and output.
48. Creatinine, Serum
Abnormal Findings- Decreased Levels
Liver disease
Deficient levels of protein in the diet.
Small build
Loss of muscle mass
Nursing Implications
Anticipate the need for additional testing.
Prepare the patient for follow-up and treatment.
Monitor fluid balance and intake and output.
49. Creatinine, Serum
Interfering Factors
Ascorbic acid, barbiturates, and diuretics (possible increase)
Exceptionally large muscle mass, such as is found in athletes
(possible increase despite normal renal function)
50. Creatinine, Serum
Nursing Considerations- Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the serum creatinine test is used to
evaluate kidney function.
Tell the patient that the test requires a blood sample.
Instruct the patient that he doesn’t need to restrict food and
fluids.
Notify the laboratory and the practitioner of medications the
patient is taking that may affect test results; they may need to
be restricted.
51. Creatinine, Serum
Nursing Considerations- During the Test
Handle the sample gently to prevent hemolysis.
After the Test
Send the sample to the laboratory immediately.
Apply direct pressure to the venipuncture site until bleeding stops.
Assess the venipuncture site for hematoma formation; if one
develops, apply pressure.
Inform the patient that he may resume his usual medications that
were discontinued before the test, as ordered.
52. Liver Function Tests (LFT)
Liver function tests are blood tests that measure different
enzymes, proteins, and other substances made by the liver.
The different substances are often tested at the same time on
a single blood sample, and may include the following:
Albumin.
Total protein.
ALP (alkaline phosphatase), ALT (alanine transaminase), AST
(aspartate aminotransferase),
Bilirubin, a waste product made by the liver.
53. Albumin
Description
The test measures the amount of albumin in serum.
Albumin is the most abundant protein, composing almost 54%
of plasma proteins
Purpose
To help determine whether a patient has liver or kidney
disease
To determine whether enough protein is being absorbed by
the body.
55. Albumin
Abnormal Findings- Elevated Levels (Hyperalbuminemia)
Dehydration
Severe vomiting
Severe diarrhea
Nursing Implications
Report abnormal findings to the practitioner.
Prepare to administer IV fluids to restore volume and
electrolytes.
Educate the patient about his disease and treatment options.
56. Albumin
Abnormal Findings- Decreased Levels (Hypoalbuminemia)
Cirrhosis
Acute liver failure
Severe burns
Severe malnutrition
Ulcerative colitis
Nursing Implications
Prepare to administer IV albumin.
Educate the patient about his disease and treatment options.
58. Albumin
Nursing Considerations - Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Inform the patient that he doesn’t need to restrict fluids.
Describe the venipuncture procedure to the patient.
Explain that certain medications can increase albumin
measurements, including anabolic steroids, androgens,
growth hormones, and insulin.
The patient may need to stop taking these drugs before the
test.
59. Albumin
During the Test
Perform a venipuncture, and collect 5 to 10 mL in a red-top
tube.
After the Test
Apply direct pressure to the venipuncture site until bleeding
stops.
Encourage the patient to eat a high protein diet, if not
contraindicated.
60. Bilirubin (Serum)
Description
The bilirubin test is used to measure serum levels of bilirubin,
the predominant pigment in bile.
Bilirubin is the major product of hemoglobin catabolism.
Serum bilirubin measurements are especially significant in
neonates because elevated unconjugated bilirubin can
accumulate in the brain, causing irreparable damage.
61. Bilirubin (Serum)
Purpose
To evaluate liver function.
To aid in the differential diagnosis of jaundice and monitor its
progress.
To help diagnose biliary obstruction and hemolytic anemia.
62. Bilirubin (Serum)
Reference Values
Adults: indirect serum bilirubin levels, 0.1 to 1.0 mg/dL (SI,
1.7–17.1 μmol/L);
Direct serum bilirubin levels, less than 0.5 mg/dL (SI, less
than 6.8 μmol/L)
63. Bilirubin (Serum)
Abnormal Findings- Elevated Levels
Hepatic damage or severe hemolytic anemia (elevated
indirect serum bilirubin).
Hemolysis (elevated indirect and direct serum bilirubin levels).
Biliary obstruction (elevated direct serum bilirubin levels).
Nursing Implications
Prepare the patient for additional testing as indicated.
64. Bilirubin (Serum)
Interfering Factors
Exposure of the sample to direct sunlight or ultraviolet light
(possible decrease).
Barbiturates and sulfonamides (possible decrease).
Precautions
Protect the sample from strong sunlight and ultraviolet light.
Handle the sample gently.
65. Bilirubin (Serum)
Nursing Considerations - Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the bilirubin test is used to evaluate
liver function and the condition of red blood cells.
Inform the patient that the test requires a blood sample from a
venipuncture.
Advise the patient that he may experience slight discomfort
from the tourniquet and needle puncture.
Inform the patient that he doesn’t need to restrict fluids, but
should fast for at least 4 hours before the test.
66. Bilirubin (Serum)
After the Test
Apply direct pressure to the venipuncture site until bleeding
stops.
Assess the venipuncture site for hematoma formation; if one
develops, apply direct pressure.
67. Coagulation Studies
Coagulation testing is useful for assessing patients' ability to
clot; for investigating the cause of a patient's coagulopathy;
and for therapeutic monitoring of certain anticoagulant
medications.
The classical coagulation profile includes:
Prothrombin time (PT)
Activated partial thromboplastin time (PTT).
68. Partial Thromboplastin Time (PTT)
Description
Also called the activated partial thromboplastin test (APTT).
The partial thromboplastin time (PTT) test is used to evaluate
all the clotting factors of the intrinsic pathway, except
platelets, by measuring the time required for formation of
a fibrin clot after calcium and phospholipid emulsion is
added to a plasma sample.
69. Partial Thromboplastin Time (PTT)
Purpose
To screen for clotting factor deficiencies in the intrinsic
pathways.
To monitor response to heparin therapy.
Reference Values
21 to 35 seconds (SI, 21–35 seconds)
Therapetic heparin therapy: 2 to 2.5 times normal limit
70. Partial Thromboplastin Time (PTT)
Abnormal Findings- Elevated Levels
Certain plasma clotting factor deficiencies.
Presence of heparin.
Vitamin K deficiency.
Genetic or acquired deficiency of clotting factors
Hemophilia A
Nursing Implications
Report abnormal findings to the practitioner.
Prepare to adjust the patient’s anticoagulant therapy as
indicated.
71. Partial Thromboplastin Time (PTT)
Decreased Levels
Extensive cancer
Nursing Implications
Report abnormal findings to the practitioner.
Prepare to adjust the patient’s anticoagulant therapy as
indicated.
72. Partial Thromboplastin Time (PTT)
Precautions
To prevent hemolysis, avoid excessive probing at the
venipuncture site and handle the sample gently.
73. Partial Thromboplastin Time (PTT)
Nursing Considerations- Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the PTT test is used to determine if
blood clots normally.
When appropriate, tell the patient receiving heparin therapy
that this test may be repeated at regular intervals to assess
his response to treatment.
Do not draw from a closed-loop blood sampling system in an
arterial line where heparin flush has been used. Do not draw
from an arm into which heparin is infused.
74. Partial Thromboplastin Time (PTT)
During the Test
Completely fill the collection tube, invert it gently several
times, and send it on ice to the laboratory
After the Test
Ensure subdermal bleeding has stopped before removing
pressure.
For a patient on anticoagulant therapy, apply additional
pressure at the venipuncture site to control bleeding.
If a hematoma develops at the venipuncture site, apply direct
pressure. If the hematoma is large, monitor pulses distal to
the venipuncture site.
75. Prothrombin Time (PT)
Description
PT measures the time required for a fibrin clot to form in a
citrated plasma sample after the addition of calcium ions and
tissue thromboplastin (factor III).
Purpose
To evaluate the extrinsic coagulation system (factors V, VII,
and X, and prothrombin and fibrinogen)
To monitor response to oral anticoagulant therapy
76. Prothrombin Time (PT)
Reference Values
10 to 14 seconds (SI, 10–14 seconds)
For a patient receiving oral anticoagulants: 1 to 2½ times the
normal control value.
Abnormal Findings
Prolonged prothrombin time (PT) (exceeding 2½ times the
control value; may result from deficiencies in fibrinogen,
prothrombin, vitamin K, or factor V, VII, or X)
Nursing Implications
Report abnormal findings to the practitioner.
Prepare to adjust the patient’s anticoagulant dosage as
indicated.
77. Prothrombin Time (PT)
Interfering Factors
Salicylates, more than 1 g/day (increase).
Antihistamines, corticosteroids, digoxin (Lanoxin), diuretics,
vitamin K (possible decrease).
Heparin IV (within 5 hours of sample collection) vitamin A, or
alcohol in excess (prolonged PT).
Antibiotics, barbiturates (possible increase or decrease).
78. Prothrombin Time (PT)
Precautions
To prevent hemolysis, avoid excessive probing during
venipuncture and handle the sample gently.
79. Prothrombin Time (PT)
Nursing Considerations- Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the PT test is used to determine if
the blood clots normally. When appropriate, explain that this
test is used to monitor the effects of oral anticoagulants.
The test will be performed daily when therapy begins and will
be repeated at longer intervals when medication levels
stabilize.
80. Prothrombin Time (PT)
Nursing Considerations- Before the Test
Inform the patient that he doesn’t need to restrict food and
fluids for the test.
Notify the laboratory and practitioner of medications the
patient is taking that may affect test results; they may need to
be restricted.
During the Test
Completely fill the collection tube and invert it gently several
times to mix the sample and the anticoagulant thoroughly.
81. Prothrombin Time (PT)
After the Test
Apply direct pressure to the venipuncture site until bleeding
stops.
If a hematoma develops at the venipuncture site, apply
pressure. If the hematoma is large, monitor pulses distal to
the venipuncture site.
Tell the patient that he may resume his usual diet and
medications discontinued before the test, as ordered.
82. Electrolyte
Electrolytes are involved in many essential processes in your
body.
They play a role in conducting nervous impulses, contracting
muscles, keeping you hydrated and regulating your body’s pH
levels.
Electrolytes found in your body include:
Sodium
Potassium
Chloride
Calcium
Magnesium
Phosphate
Bicarbonate
83. Sodium, Serum
Purpose
To evaluate fluid, electrolyte, and acid–base balance and
related neuromuscular, renal, and adrenal functions.
Reference Values
Adults and children: 135 to 145 mEq/L (SI, 135–145 mmol/L)
84. Sodium, Serum
Critical Values
Less than 120 mEq/L (SI, 120 mmol/L) or
greater than 160 mEq/L (SI, greater than 160 mmol/L)
86. Sodium, Serum
Nursing Implications
Report abnormal findings to the practitioner.
Observe the patient for hypernatremia (Na+ greater than 135)
and associated water loss, signs of thirst, restlessness, dry
and sticky mucous membranes, flushed skin, oliguria, and
diminished reflexes.
If increased total body sodium causes water retention,
observe for hypertension, dyspnea, edema, and heart failure.
Prepare the patient for further testing as indicated.
88. Sodium, Serum
Nursing Implications - Decreased Levels
Report abnormal findings to the practitioner.
In the patient with hyponatremia, watch for apprehension,
headache, decreased skin turgor, abdominal cramps, and
tremors that may progress to seizures.
Prepare the patient for further testing as indicated.
89. Sodium, Serum
Interfering Factors
Most diuretics (decrease by promoting sodium excretion).
Corticosteroids (increase by promoting sodium retention).
Antihypertensives (possible increase due to sodium and water
retention)
90. Sodium, Serum
Precautions
Handle the sample gently to prevent hemolysis.
Nursing Considerations- Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the serum sodium test is used to
determine the sodium content of the blood.
Inform the patient that he doesn’t need to restrict food and
fluids for the test.
91. Sodium, Serum
After the Test
Apply direct pressure to the venipuncture site until bleeding
stops.
If a hematoma develops at the venipuncture site, apply direct
pressure.
Instruct the patient to resume any medications that were
discontinued before the test, as ordered.
92. Potassium, Serum
Purpose
To evaluate clinical signs of potassium excess (hyperkalemia)
or potassium depletion (hypokalemia).
To monitor renal function, acid–base balance, and glucose
metabolism.
To evaluate neuromuscular and endocrine disorders.
To detect the origin of arrhythmias.
94. Potassium, Serum
Nursing Implications - Elevated Levels
Report abnormal findings to the practitioner
Observe the patient with hyperkalemia for weakness, malaise,
nausea, diarrhea, colicky pain, muscle irritability progressing
to flaccid paralysis, oliguria, and bradycardia.
Observe the electrocardiogram (ECG) changes
95. Potassium, Serum
Decreased Levels
Cushing’s syndrome.
Body fluids loss (such as long term diuretic therapy, vomiting,
or diarrhea).
Draining wounds.
Cystic fibrosis.
Severe burns.
Diuretic, antibiotic.
96. Potassium, Serum
Nursing Implications - Decreased Levels
Observe the patient with hypokalemia for decreased reflexes;
a rapid, weak, irregular pulse; mental confusion; hypotension;
anorexia; muscle weakness; and paresthesia.
Monitor the ECG changes.
97. Potassium, Serum
Interfering Factors
Repeated clenching of the fist before venipuncture (possible
increase).
Excessive or rapid potassium infusion, spironolactone or
penicillin (increase)
Insulin and glucose administration; diuretic therapy
(especially with thiazides decrease)
98. Potassium, Serum
Precautions
Draw the sample immediately after applying the tourniquet
because a delay may increase the potassium level.
Handle the sample gently to prevent hemolysis.
In severe cases, ventricular fibrillation, respiratory paralysis,
and cardiac arrest can develop. (Cardiac arrest may occur
without warning.)
99. Potassium, Serum
Nursing Considerations - Before the Test
Confirm the patient’s identity using two patient identifiers
according to facility policy.
Explain to the patient that the serum potassium test is used to
determine the potassium content of blood.
Advise the patient that the test requires a blood sample.
Explain that he may experience slight discomfort from the
needle puncture and the tourniquet.
Inform the patient that he doesn’t need to restrict food and
fluids for the test.
100. Potassium, Serum
After the Test
Apply direct pressure to the venipuncture site until bleeding
stops.
If a hematoma develops at the venipuncture site, apply direct
pressure.
Tell the patient to resume medications that were discontinued
before the test, as ordered.
101. Reference
Brunner & Suddarth’s. (2010). Handbook of Laboratory and Diagnostic Tests.
Wolters Kluwer Health, Lippincott Williams & Wilkins.